Abstract
FOR some years we have been investigating the biological properties of substituted phenylalkanoic and phenoxy-alkanoic acids and related compounds. We wish to describe briefly the properties of one of these, ‘Ibufenac’, which Chalmers and Duthie have recently shown to be effective in the treatment of rheumatoid arthritis1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chalmers, T. M., and Duthie, J. J. R., Ann. Rheum. Dis. (in the press).
Adams, S. S., and Cobb, R., Nature, 181, 773 (1958).
Randall, L. O., and Selitto, J. J., Arch. Int. Pharmacodyn., 111, 409 (1957).
Silber, R. H., Ann. N.Y. Acad. Sci., 82, 821 (1959).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ADAMS, S., CLIFFE, E., LESSEL, B. et al. Some Biological Properties of ‘Ibufenac’, a New Anti-rheumatic Drug. Nature 200, 271–272 (1963). https://doi.org/10.1038/200271b0
Issue Date:
DOI: https://doi.org/10.1038/200271b0
This article is cited by
-
Diaryloxazole and Diarylthiazolealkanoic Acids: Two Novel Series of Non-steroidal Anti-inflammatory Agents
Nature (1968)
-
Inhibition of Conjugation by Anti-inflammatory Drugs
Nature (1965)
-
Uncoupling of Oxidative Phosphorylation by some Arylacetic Acids (Anti-inflammatory or Hypocholesterolemic Drugs)
Nature (1964)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
